18 and older, any sex, with Nephrolithiasis. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Visual Analog Scale (VAS) Pain ScoresPrimary· post-op day 5 and post-op day 10
Visual Analog Scale (VAS) to measure pain: The minimum score of '0' indicates "no pain" and the maximum score of '10' indicates "Worst pain imaginable" along a line. Participants will be asked to mark the level of their pain along the line. Visual analog scale (VAS) pain scores will be recorded
post-op day 5
Group
Value
95% CI
Opioid Group
4.5
3 – 7
NSAID
5
3 – 6
post-op day 10
Group
Value
95% CI
Opioid Group
1
0 – 2
NSAID
1
0 – 3
Pill CountSecondary· post-op at day 10
A pill count will be conducted of each prescribed postoperative medication.
Group
Value
95% CI
Opioid Group
6.5
± 5
NSAID
12
± 6
Number of Participants Who Called the OfficeSecondary· post-op up to day 10
Number of participants with pain related calls to the office recorded.
Group
Value
95% CI
Opioid Group
5
NSAID
8
Number of Participants With Pain Related VisitsSecondary· post-op up to day 10
Number of participants with pain related visits to the office or Emergency Department (ED) visits recorded.
Group
Value
95% CI
Opioid Group
3
NSAID
2
Patient-related Outcome Survey (PROMIS) ScoresSecondary· post-op at day 10
Patients given a survey containing questions from Patient-related outcome survey (PROMIS) instruments.
A series of person-centered measures that evaluate and monitor physical, mental, and social health in adults and children. 10-item patient-reported questionnaire. standardized to the general population, using the "T-Score". The average "T-Score" for the United States population is 50 points, with a standard deviation of 10 points. Higher scores indicate a healthier patient.
Group
Value
95% CI
Opioid Group
10
7 – 13
NSAID
10
8 – 15
Sponsor's own description
This is a randomized control trial comparing oral ketorolac and opioid medication for the use of post-operative analgesia.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT07360353 — Comparison Between Different Types of Flexible Ureteroscopes
· NA
· recruiting
NCT07261995 — Comparison of Extracorporeal Shock Wave Lithotripsy Versus Retrograde Intrarenal Surgery in the Management of Renal Calc
· NA
· recruiting
NCT07138872 — Hemodynamic Effects of Surgical Position in Prone vs. Supine Percutaneous Nephrolithotomy
· NA
· recruiting
NCT06989320 — Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
· NA
· recruiting
NCT07058402 — RIRS With Flex Suction Sheath vs. PCNL for 2-3 cm Renal Stones
· NA
· recruiting
Other Icahn School of Medicine at Mount Sinai trials
Trials by the same sponsor.
NCT07094308 — The LIFT-ECHO Last Mile Project
· NA
· not yet recruiting
NCT07291427 — Chronic Subdural Hematoma Embolization With Detachable Coils
· not yet recruiting
NCT07194187 — High Intensity Focused Ultrasound (HIFU) Ablation for Treatment of Prostate Tissue in Bladder Outlet Obstruction
· NA
· not yet recruiting
NCT07260916 — Minimally Invasive Neuroendoscopic Ultra-Early Targeted ICH Evacuation
· NA
· not yet recruiting
NCT07487948 — Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and
· Phase 2
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Icahn School of Medicine at Mount Sinai
Last refreshed: 26 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05924165.